Evaluation of the Efficacy and Safety of CollaSel PRO® Type I and Type III Hydrolyzed Collagen Peptides in the Treatment of Osteoarthritis: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Evaluation of the Efficacy and Safety of CollaSel PRO® Type I and Type III Hydrolyzed Collagen Peptides in the Treatment of Osteoarthritis: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial.
- Published In:
- Journal of clinical medicine, 14(11) (2025)
- Authors:
- Demir-Dora, Devrim, Tuna, Serpil, Kurtoglu, Emel Dogan, Gursoy, Savas, Balci, Nilufer, Tezman, Selim, Erenmemisoglu, Aydin
- Database ID:
- RPEP-10686
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-10686APA
Demir-Dora, Devrim; Tuna, Serpil; Kurtoglu, Emel Dogan; Gursoy, Savas; Balci, Nilufer; Tezman, Selim; Erenmemisoglu, Aydin. (2025). Evaluation of the Efficacy and Safety of CollaSel PRO® Type I and Type III Hydrolyzed Collagen Peptides in the Treatment of Osteoarthritis: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial.. Journal of clinical medicine, 14(11). https://doi.org/10.3390/jcm14113655
MLA
Demir-Dora, Devrim, et al. "Evaluation of the Efficacy and Safety of CollaSel PRO® Type I and Type III Hydrolyzed Collagen Peptides in the Treatment of Osteoarthritis: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial.." Journal of clinical medicine, 2025. https://doi.org/10.3390/jcm14113655
RethinkPeptides
RethinkPeptides Research Database. "Evaluation of the Efficacy and Safety of CollaSel PRO® Type ..." RPEP-10686. Retrieved from https://rethinkpeptides.com/research/demir-dora-2025-evaluation-of-the-efficacy
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.